|Original language||English (US)|
|Journal||Obstetrics and Gynecology Clinics of North America|
|State||Published - 1991|
ASJC Scopus subject areas
- Obstetrics and Gynecology
Other files and links
In: Obstetrics and Gynecology Clinics of North America, Vol. 18, No. 1, 1991, p. ix.
Research output: Contribution to journal › Editorial › peer-review
TY - JOUR
T1 - Perface
AU - Diamond, M. P.
AU - DeCherney, A. H.
N1 - Funding Information: Y. Shimomura firstname.lastname@example.org ITER Naka Joint Work Site, 801-1 Mukouyama, Naka-machi Naka-gun, Ibaraki-ken 311-0193 Japan This issue of Fusion Engineering and Design reviews the ITER Technology R&D. ITER is planned to be the first fusion experiment operating under reactor-relevant conditions aimed at demonstrating the scientific and technological feasibility of fusion energy for peaceful purposes. The ITER Technology R&D has been conducted cooperatively by the European Atomic Energy Community (EU) with Canada as associate, Japan (JA), the Russian Federation (RF) with Kazakhstan as associate, and the United States of America (US), until July 1999, under the ITER Engineering Design Activity Agreement during July 1992–July 2001. The objectives of this R&D are not only to develop key technologies but also to demonstrate the manufacturing of full-scale or scalable models of major tokamak components so that the construction of ITER will be able to start with a high confidence. The overall R&D programme has been developed by the ITER Director, Dr. R. Aymar and the Deputy to the Director, Dr. Y. Shimomura. The four Home Teams led by Prof. R. Toschi (July 1992–July 2000)/Prof. K. Lackner (July 2000–July 2001) in the EU, Dr. S. Matsuda (July 1992–July 1998)/Dr. T. Tsunematsu (July 1998–July 2001) in the JA, Dr. O. Filatov in the RF, and Dr. C. Baker in the US have been sharing the R&D based on task agreements between the Director and each responsible Home Team Leader. The total number of the task agreements is 650, and the work has been progressed by numerous contributions at institutes, universities, industries as well as fusion laboratories, as shown in the list of contributors. The work has developed a rigorous technical basis of ITER. As a member of the ITER project and as the Guest Editor of this issue, I should like to express my appreciation and gratitude to all contributors to the R&D and to this issue for their great efforts. Progress of the ITER technology R&D has been increasing not only the confidence of success for the ITER Project, but also the technical base of magnetic fusion reactor development. Based on the output of the ITER Engineering Design Activities including the technology R&D, the Joint Implementation of the ITER Project is under discussion among the interested Parties, aiming to start ‘the ITER Construction, Operation, Exploitation and Decommissioning Activities’ in 2003.This special issue includes work undertaken within the framework of the ITER EDA Agreement. The views and opinions expressed herein do not necessarily reflect those of the Parties to the ITER EDA Agreement, the IAEA or any agency thereof. Dissemination of the information in this issue is governed by the application terms of the ITER EDA Agreement.
PY - 1991
Y1 - 1991
UR - http://www.scopus.com/inward/record.url?scp=0026058142&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026058142&partnerID=8YFLogxK
M3 - Editorial
AN - SCOPUS:0026058142
SN - 0889-8545
VL - 18
SP - ix
JO - Obstetrics and Gynecology Clinics of North America
JF - Obstetrics and Gynecology Clinics of North America
IS - 1